$PSID The company’s commercial diagnostics product is called Firefly Dx. This product was developed for the $27 billion dollar commercial diagnostics market. It is a rapid medical testing device that is highly effective, portable, and much faster than traditional diagnostic methods. The company has made agreements with entities such as NASA, ENSCO, and USSOCOM already. They are expecting Firefly Dx to create a significant pipeline for revenue in 2015/2016.